Drug Trial Radar · NCT03402945
Prevention of Infections in Cardiac Surgery (PICS) Prevena Study
Last checked: Nov 19, 2026Latest source record: Feb 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,107
Actual
Start
Mar 5, 2018
Primary completion
Apr 27, 2023
Study completion Oct 17, 2024
Sponsor
- Lead sponsor
- Population Health Research InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 18, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This vanguard study will be conducted at two study sites in Canada. It is a cluster randomized trial to test a combination of two antibiotics for antibiotic prophylaxis as compared to routine prophylaxis with one single antibiotic, and to test a negative-pressure wound management system (Prevena) versus standard wound dressing to reduce chest wound infections.
Conditions
- Surgical Site Infections
Interventions
PrevenaDevice
Negative-Pressure Wound Management System
CefazolinDrug
antibiotic
VancomycinDrug
antibiotic
standard wound dressingOther
Any non-negative pressure wound dressing that is routinely used at study sites will be considered standard of care in the control arms.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adherence to the wound management systemTime frame: Prevena or standard wound dressing applied after surgery as per protocol, assessed up to 90 days after surgery
- Adherence to the antibiotic regimenTime frame: Cefazolin: within an hour of surgery; one intra-operative dose at 4 hours after the first dose or upon wound closure (whatever comes first); two post-operative doses q8h. Vancomycin: initially intravenously; second dose 12 hrs after the first dose.
- Loss of follow-upTime frame: up to 90 days after surgery
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Hamilton General Hospital
Hamilton, Ontario, Canada
London Health Sciences Centre & Lawson Health Research Institute
London, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.